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Evolution of dosage compensation under sexual
selection differs between X and Z chromosomes
Charles Mullon1,2,3, Alison E. Wright1,4, Max Reuter1, Andrew Pomiankowski1,2 & Judith E. Mank1
Complete sex chromosome dosage compensation has more often been observed in XY than
ZW species. In this study, using a population genetic model and the chicken transcriptome,
we assess whether sexual conﬂict can account for this difference. Sexual conﬂict over
expression is inevitable when mutation effects are correlated across the sexes, as compen-
satory mutations in the heterogametic sex lead to hyperexpression in the homogametic
sex. Coupled with stronger selection and greater reproductive variance in males, this results
in slower and less complete evolution of Z compared with X dosage compensation. Using
expression variance as a measure of selection strength, we ﬁnd that, as predicted by the
model, dosage compensation in the chicken is most pronounced in genes that are under
strong selection biased towards females. Our study explains the pattern of weak dosage
compensation in ZW systems, and suggests that sexual selection plays a major role in
shaping sex chromosome dosage compensation.
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S
ex chromosomes diverge following the suppression of
recombination, which results in the decay of the non-
recombining Y or W sex chromosomes1. The degradation
of Y- and W-linked genes causes a reduction in expression levels
in the heterogametic sex2,3, which retains only one copy of X- or
Z-linked loci. This decrease in expression can have a negative
effect on the ﬁtness of the heterogametic sex (XY in male and ZW
in female heterogamety). The deleterious effects of Y and W
degradation are thought to drive the evolution of dosage
compensation, where selection acts to increase expression in the
heterogametic sex and so restore the expression level that existed
prior to sex chromosome divergence4,5.
Ohno4 suggested that complete dosage compensation
would follow gene loss on the Y or W chromosome, and many
assumed that complete dosage compensation was an essential
feature of all heteromorphic sex chromosomes. However,
expression data shows that dosage compensation varies widely
among taxa. Some species, such as Drosophila melanogaster6,7
and Caenorhabditis elegans8,9, achieve near complete dosage
compensation across the entire X chromosome. This has been
observed in several other male heterogametic (XY) species
(Table 1). In contrast, complete dosage parity has only been
observed in one female heterogametic (ZW) species10. All other
female heterogametic species thus far studied display incomplete
dosage compensation, with some individual genes compensated,
but the average expression of female Z-linked genes below that of
the two copies in males, and below the average expression of
autosomal copies in females (Table 1, Supplementary Table 1).
Age of sex chromosome system does not explain the distribution
of incomplete versus complete dosage compensation, as both
birds and Lepidoptera possess relatively old, highly conserved
sex chromosome systems that are largely uncompensated11.
The term incomplete dosage compensation in Table 1 includes
several different possible regulatory states, ranging from dosage
compensation for a subset of genes to partial compensation
for a large proportion of genes. Although it is not possible to
differentiate these various forms of incomplete dosage
compensation, the striking difference between male and female
heterogamety suggests that the evolution of dosage compensation
is inﬂuenced by different forces in X and Z chromosomes.
Here we build a population genetic model in which dosage
compensation arises through the accumulation of cis-regulatory
mutations that alter the expression of X- or Z-linked genes12.
To be consistent with our subsequent data analysis, we deﬁne
dosage compensation as the evolution of equal expression
in males and females following the loss of the Y or W allele in
the heterogametic sex. As correlations in expression between the
sexes are typically strongly positive13,14, we allow mutations
altering expression in one sex to cause correlated change in the
other sex. Therefore, mutations that increase expression in the
heterogametic sex to compensate for reduced unbalanced
selection between the sexes may lead to hyperexpression in the
homogametic sex, resulting in sexually antagonistic ﬁtness effects.
When there is sexual conﬂict, the adaptive response is dominated
by the sex under stronger selection15,16. In addition, in the case of
sex chromosomes, selection is greater in the homogametic sex
relative to that in the heterogametic sex17. As the Z chromosome
resides two-thirds of the time in males while the X chromosomes
resides two-thirds of the time in females, selection on males has a
disproportionate effect on the Z and selection on females has a
disproportionate effect on the X. Finally, the efﬁcacy of selection
on a mutation can differ according to its location on the Z or the
X chromosome. Reproductive variance may vary between the
sexes, and is often higher in males18,19. This affects Z and X
chromosomes differently, as the Z chromosome is more sensitive
to increased male reproductive variance than the X16,20–22,
lowering the rate of adaptation on the Z relative to that on the X.
We examine how the combination of these forces results in
differences between XY and ZW systems in the evolutionary rates
of dosage compensation, and ﬁnd that slower and less complete Z
dosage compensation evolution is associated with a positive
correlation in mutational effects across the sexes, stronger
selection on males and greater male reproductive variance. Our
model also predicts that dosage compensation should be most
pronounced in genes that are under strong selection, biased
towards the heterogametic sex. Using expression variance as a
measure of selection strength on expression, we ﬁnd support for
these predictions from the chicken transcriptome.
Results
Rates of dosage compensation evolution. In the model (see
Methods for details), expression evolves via the recurrent ﬁxation
of cis-regulatory mutations of small effect, consistent with pre-
vious studies of gene expression evolution23. We assume that
mutations are sufﬁciently rare for each one to be ﬁxed or lost
before another arises. Mutations cause small changes dm and df in
male and female expression relative to the resident allele
(Table 2). We assume that the variance of mutational effects dm
and df is ﬁxed to a constant value (Var[dm]¼Var[df]¼ 0.1). The
scope for sexually antagonistic effects is determined by the
correlation r between the effects of mutation in the two sexes,
which can be independent (r¼ 0), similar (r40) or opposed
(ro0). The model assumes that gene expression in the
Table 1 | Current status of dosage compensation.
Species or clade Karyotype
(female:male)
Average sex chromosome
dosage compensation
Caenorhabditis elegans XX:XO Complete
Drosophila
melanogaster
XX:XY Complete
Teleopsis dalmani XX:XY Complete
Anopheles gambiae XX:XY Complete
Tribolium castaneum* XX:XY Complete in males
Xenos vesparum XX:XY Incomplete in new region,
complete in old region shared
with Tribolium
Gasterosteus aculeatus XX:XY Incomplete
Ornithorhynchus
anatinusw
XX:XY Incomplete
Monodelphis
domestica
XX:XY Complete
Eutherian mammalsz XX:XY Complete for dosage sensitive
genes
Silene latifolia XX:XY Unclear
Rumex hastatulus XX:XY Incomplete
Schistosoma mansoni ZW:ZZ Incomplete
Lepidoptera ZW:ZZ or
ZO:ZZ
Ranges from incomplete
to complete
Cynoglossus semilaevis ZW:ZZ Incomplete
Serpentes ZW:ZZ Incomplete
Aves ZW:ZZ Incomplete
Recent studies (see Supplementary Table 1 for references) have assessed the presence or
absence of complete dosage compensation by comparing the average X or Z expression to the
average autosomal expression in the heterogametic (Xmale:AAmale or Zfemale:AAfemale) and
homogametic (XXfemale:AAfemale or ZZmale:AAmale) sex.
*Tribolium exhibits X chromosome dosage compensation in males, although this appears to have
resulted in hyperexpression of X-linked genes in females47.
wThe Platypus has ﬁve separate X chromosomes (X1, X2, X3, X4, X5), which are diploid in females
and matched by ﬁve Y chromosomes (Y1, Y2, Y3, Y4, Y5) in males.
zRecent work in the therian mammals indicates that dosage-sensitive genes are compensated in
both sexes48, through the evolution of female X chromosome inactivation and upregulation of
the single active X in both sexes. However, X:AA and XX:AA ratios areo1 for a small number of
dosage-insensitive genes and genes with active Y homologues.
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homogametic sex is additive and taken to be the sum of the effects
of the alleles carried by an individual (Table 2). Expression is
assumed to be under stabilizing selection, with the optimum
expression arbitrarily set to zero and symmetric decline following
a Gaussian function (Table 2). Although stabilizing selection
operates in both sexes, its intensity in males and females, denoted
by Sm and Sf, may differ (Table 2).
Assuming that gene expression is at the optimum before
degradation of the Y or W allele occurs, the heterogametic sex
initially suffers a decrease of  z0 in expression, where z0 is the
expression contribution of the Y/W chromosome prior to
degradation. Expression in the homogametic sex is unaffected
and remains at the optimum level. The evolutionary trajectory
from this starting point depends on the ﬁxation probability of
newly arising mutations. This depends on the sex-speciﬁc
selection pressure acting on a mutant, given by Sm and Sf, and
the effective population size NeX or NeZ, which scale with the level
of sex-speciﬁc variance in reproductive success24. Iterating this
mutation-ﬁxation process and integrating across the distribution
of mutational effects dm and df, the expected rates of change in
male (zm) and female (zf) expression are given by
dzm
dt
¼ NeX Smzmþ 2rSf zfð Þ ð1Þ
dzf
dt
¼  2NeX rSmzmþ 2Sf zfð Þ ð2Þ
dzm
dt
¼  2NeZ 2Smzmþ rSf zfð Þ ð3Þ
dzf
dt
¼ NeZ 2rSmzmþ Sf zfð Þ ð4Þ
for XY (equations (1) and (2)) and ZW (equations (3) and (4))
species. Evolutionary time t in equations (1)–(4) is scaled with
respect to the mutation rate. This means that a unit of t
corresponds to fewer generations when the mutation rate is
higher. Equations (1)–(4) highlight how the evolution of X- and
Z-linked gene expression depends on the asymmetry in sex
chromosome dose (two in the homogametic and one in the
heterogametic sex), the inter-sexual correlation in expression (r),
the balance between selection in males and females (Sm and Sf)
and the effective population size (NeX and NeZ).
Given sufﬁcient time, the model predicts that both XY and ZW
systems will evolve complete dosage compensation for genes
whose expression levels depend on gene dose, where expression
in the heterogametic sex converges to the ancestral level and
males and females reach their respective ﬁtness optima (zm¼ 0
and zf¼ 0).
In the absence of any inter-sexual correlation in mutational
effects (r¼ 0), the evolutionary dynamics of dosage compensa-
tion are governed by the strength of selection on the
heterogametic sex alone. The heterogametic sex returns to the
optimal level at an exponential rate  z0eNeXSmt in XY species,
and  z0eNeZSf t in ZW species. If the effective population sizes
and the mutation rates are the same for the X and Z
chromosomes and selection is equivalent in males and females
(Sm¼ Sf), complete dosage compensation will be attained at the
same rate in both XY and ZW systems.
The speed with which dosage compensation evolves is
dramatically reduced under the more plausible assumption that
mutations have correlated effects across the sexes (ra0). When
mutational effects are positively correlated (r40), mutations that
increase expression and improve dosage compensation in the
heterogametic sex are associated with antagonistic ﬁtness effects
in the other sex, as they raise expression in the homogametic sex
above the ﬁtness optimum. As the homogametic sex carries more
chromosomal copies, antagonistic effects impede selection in
favour of dosage compensation in the heterogametic sex. If
selection is equal between males and females (Sm¼ Sf), the
expectation is that dosage compensation will be slow to evolve
both for Z- (Fig. 1a) and X-linked genes (Fig. 1b).
However, selection is typically stronger in males (Sm4Sf) as a
result of sexual selection25–28. This creates markedly different
evolutionary trajectories of dosage compensation. For Z-linked
genes, the combination of male homogamety with more intense
selection in males maintains male expression near its optimum
(Fig. 1c). Only mutations that increase female expression while
minimally affecting males are favoured (Fig. 1c). With a positive
inter-sexual correlation for mutational effects (r40), the
frequency with which such suitable mutations arise is low and
the rate at which dosage compensation evolves is very slow
(Fig. 1c).
The slow and gradual trajectory of Z-linked genes contrasts
with more rapid and sexually antagonistic dynamics for X-linked
genes (Fig. 1d). Here more intense selection on males (Sm4Sf)
compensates for male X chromosome monosomy, and the
evolution of dosage compensation proceeds rapidly. But it does
so at a pronounced cost to females, which are displaced from
their optimal expression (Fig. 1d). This effect is greater the higher
the correlation of mutational effects (r). Once males approach
their optimum expression level, the selective advantage of further
change in male expression decreases, and selection on females
becomes increasingly important. This causes female expression to
slowly evolve back towards the optimum through the ﬁxation of
rare mutations that simultaneously relieve the antagonistic effects
on female expression while allowing male expression to remain
close to its optimum.
Our baseline model assumes additive effects on expression and
the instantaneous loss of the W or Y allele. However, we also
consider dominance effects on expression and progressive loss of
the W or Y allele (see Methods for details). Neither of these
variants change our result that dosage compensation evolves
Table 2 | Sex-speciﬁc expression in male and female heterogametic systems.
Male Female
Genotype Expression Fitness Genotype Expression Fitness
Male heterogamety (XY) R zm e
 Smzm RR zf e Sfzf
RM zfþdf e Sf zf þ dfð Þ
M zmþ dm e Sm zm þ dmð Þ MM zfþ2df e Sf zf þ 2dfð Þ
Female heterogamety (ZW) RR zm e
 Smzm R zf e Sfzf
RM zmþ dm e Sm zm þ dmð Þ
MM zmþ 2dm e Sm zm þ 2dmð Þ M zfþ df e Sf zf þ dfð Þ
The resident allele (R) has expression level zm in males and zf in females. The mutant allele (M) causes a small quantitative shift of dm and df in males and females, respectively.
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faster on the X than on the Z in the presence of more intense
selection on males and positive inter-sexual correlation of
mutational effects (Supplementary Figs 1 and 2). However, in
both cases, the evolutionary trajectory of X expression in females
is altered compared with our baseline model. Because selection is
more efﬁcient at purging dominant deleterious alleles, the
overshoot of X expression in females is mitigated in the presence
of dominant mutations (Supplementary Fig. 1). Also, when
expression of the Y allele slowly degrades, selection on males to
compensate is weaker, and as a result causes weaker detrimental
effects to females, whose X expression remains closer to its
optimal value (Supplementary Table 2, Supplementary Fig. 2).
The role of effective population size. The evolutionary dynamics
at Z- and X-linked genes also depend on the chromosomes’
effective population sizes NeZ and NeX in equations (1)–(4).
Larger Ne results in faster evolution of dosage compensation, due
to the more reliable ﬁxation of positively selected mutations and
elimination of negatively selected mutations (Fig. 2). With
effective population size inversely proportional to the stochasti-
city in replicate evolutionary paths, small values of Ne not only
slow down the evolution of dosage compensation but also result
in more variable expression levels across replicate evolutionary
trajectories. This effect is observed both during adaptation
(Fig. 2), as well as at the evolutionary equilibrium (equation (15)).
Differences in ecology or mating systems (and hence Ne) could
underlie variation in the rate at which dosage compensation
evolves. Under simplifying assumptions29, the effective
population sizes of the Z and X chromosomes in a population
reproducing under harem polygamy are NeZ¼ 9Nf/(6þ 4Z) and
NeX¼ 9Nf/(6þ 2Z), where Nf is the number of successfully
breeding females and Z is the ratio of the number of successfully
breeding females to successfully breeding males. As two-thirds of
the Z chromosomes are transmitted by males each generation,
compared with only one-third of X chromosomes, greater
variance in male reproductive success (Z41) leads to a more
marked diminution of NeZ than NeX. This predicts slower and
more stochastic evolution of dosage compensation on the Z than
on the X (Fig. 2).
Empirical tests of model predictions. The model predicts that
whenever selection is more intense on males (Sm4Sf), the evo-
lution of dosage compensation is more rapid and efﬁcient in
species with XY as opposed to ZW sex determining systems. This
expectation ﬁts broadly with the limited amount of available data
on average sex chromosomal expression levels (Table 1). A more
rigorous and powerful test can be performed by analysing var-
iation in individual gene expression patterns within sex chro-
mosomes. In particular, an important model prediction is that
dosage compensation should be more prevalent among genes
subject to strong selection, and in genes where selection is
stronger in the heterogametic sex. We addressed these questions
using transcriptome data from chicken, a species previously
shown to have incomplete Z chromosome dosage compensa-
tion30. To gauge the strength of selection on individual genes in
the two sexes, we measured the sex-speciﬁc variability of
transcript levels due to differences in expression levels between
biological replicates (biological coefﬁcient of variation (BCV); see
Methods)31,32. The assumption is that genes under stronger
purifying selection show less expression variation between
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Figure 1 | The evolution of dosage compensation on Z and X
chromosomes. Expected gene expression is shown for males (blue) and
females (red) under a very low (r¼0.1, dotted line), intermediate (r¼0.5,
dashed line) and strong inter-sexual correlation (r¼0.8, solid line)—(see
equations (13) and (14) for dynamics). a,b show equal selection in males
and females (Sm¼ Sf¼0.5); c,d show stronger selection in males (Sm¼ 1,
Sf¼0.1). Evolutionary time refers to the number of generations, ignoring
the time taken by successive mutations to ﬁx. Expression is scaled
according to the initial degradation z0 of expression in the heterogametic
sex due to the loss of one gene copy, which here is set at z0¼ 1. Other
parameters were also held equal across the two sex chromosome systems
(NeX¼NeZ¼ 1125, m¼0.0003).
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Figure 2 | Variance in male reproductive success and the evolution of
dosage compensation. Stochastic evolutionary trajectories of male (blue)
and female (red) expression for (a) Z-linked and (b) X-linked genes (see
equations (11) and (12) for dynamics). Levels of expression are shown for
low (Z¼ 1, light shade), intermediate (Z¼ 3, intermediate shade) or high
(Z¼ 10, dark shade) degrees of male reproductive variance (the number of
successful breeding females is set at 1,000). A sample of 5 trajectories is
shown for each parameter value. Variance in heterogametic sex expression
for (c) Z-linked and (d) X-linked genes after the end of the simulation is
shown as a frequency distribution for 1,000 replicates. Selection is stronger
on males than on females (Sm¼ 1, Sf¼0.2), inter-sexual correlation is
relatively strong (r¼0.6) and the mutation rate is m¼0.0003.
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biological samples. Our approach follows an increasing number
of studies using variance as an indicator of selection on gene
expression levels31–35. It is important to note, however, that the
assumptions have not been fully validated experimentally, and so
should be interpreted with caution.
A set of preliminary analyses supported our estimates of BCV
as informative measures for selection strength. First, we observed
a negative relationship between BCV and average expression in
all tissues and both sexes (Supplementary Table 3). This shows
that our estimation procedure successfully removed the positive
association between mean and variance that is expected in
Poisson-distributed read count data. The negative association is
also in line with data from other species36 showing that more
highly expressed genes are under tighter selective constraint.
Second, we also observed a positive association between BCV and
the rate of protein evolution (measured as the rate of non-
synonymous to synonymous substitutions, dN/dS, along the
terminal chicken branch; Supplementary Tables 4 and 5). Such
an association has been previously observed in vertebrates37–39
and insects33,40,41 and implies that genes under more intense
purifying selection on expression level also tend to be under
stronger purifying selection on protein sequence. Importantly, the
positive relationship between expression variance and dN/dS
occurs over and above a negative association between average
expression level and rates of protein evolution that is observed in
other species42.
Comparing estimates of male and female BCV, we ﬁnd that
across all autosomal and Z-linked genes expression variation is
greater in females than males for all three tissues we analysed
(Wilcoxon test on difference between male and female BCV;
liver: V¼ 851,261, Po0.0001, N¼ 9,196; heart: V¼ 21,797,411,
Po0.0001, N¼ 9,790; gonad: V¼ 1,240,318, Po0.0001,
N¼ 11210). The same difference is also found when analysing
autosomal genes alone (liver: V¼ 698,999, Po0.0001, N¼ 8,333;
heart: V¼ 17,969,183, Po0.0001, N¼ 8,857; gonad: V¼ 971,978,
Po0.0001, N¼ 10,086). These results support the notion that
selection is more intense on male expression.
We analysed whether the degree of dosage compensation of
individual Z-linked genes (measured as log2 of the ratio of male-
to-female expression, see Methods) is related to our measure of
selection strength on expression in the two sexes. Because the
strength of selection in males and females is positively correlated
across loci, we ﬁrst transformed our measures of male and female
expression variability into two perpendicular components, one
that measures the strength of sexually concordant selection on
expression and the other that measures male (or female) bias in
selection intensity. We then related the pattern of dosage
compensation across genes expressed in three tissues (heart, liver
and gonad) to their value along these axes of selection.
We found that both measures of selection have a signiﬁcant
effect on the male-to-female expression ratio, but that this effect
differs between the tissues (tissue-by-selection interactions in
Supplementary Table 6). The nature of these differences is best
illustrated by analyses run separately on data liver, heart and
gonad. In liver, we found that the male-to-female expression ratio
decreases with the strength of concordant selection and increases
with male-biased selection (Supplementary Table 7, Fig. 3). A
signiﬁcant interaction between the two selection measures further
showed that the effect of male-bias in selection intensity is more
pronounced when the strength of concordant selection is weak.
This means that, as predicted by our model, dosage compensation
is most pronounced in genes that are under strong selection in
both sexes and those where selection intensity is biased towards
females. In contrast to liver, genes expressed in heart showed no
relationship between male-to-female expression ratio and either
selection measure, while in the gonads we detect only a weak
signal for a positive relationship between male-to-female expres-
sion ratio and concordant selection strength (Supplementary
Table 7, Supplementary Fig. 3).
The model makes the additional prediction that the degree of
dosage compensation should increase over time. We assessed this
by comparing male-to-female expression ratios across three well-
supported strata identiﬁed within the chicken Z chromosome.
These have been estimated to have diverged from the W
chromosome for 75–106mya (Stratum 1), 45–71mya (Stratum
2) and 36–68mya (Stratum 3)43. Our model makes the qualitative
prediction that if dosage compensation evolves slowly (relative to
the age of these strata), then genes on older strata should show
more similar (less male biased) expression between the sexes
than genes on younger strata. However, our data show no
relationship between dosage compensation and the age of the
strata (Supplementary Table 8). We obtained qualitatively
identical results when we examined the female Z to autosomal
expression across strata (Supplementary Table 9); however, the
power of these analyses is limited due to the low number of genes
in each stratum. This suggests that the evolution of effective
dosage compensation occurs within a time range shorter than the
age of the youngest chicken stratum (36–68mya). Furthermore,
the persistence of many genes that lack dosage compensation
across the strata and the absence of a decrease in their frequency
through time suggests either that the genes without dosage
compensation have no or little effect on ﬁtness or that persistent
sex differences in their expression are accommodated by changes
elsewhere in the genome.
Discussion
Our model predicts that XY and ZW systems can differ
substantially in the rate with which dosage compensation
evolves and the trajectory taken by male and female expression
over the course of evolution. In particular, the evolution of
dosage compensation will be slower and more stochastic in ZW
than XY systems whenever the inter-sexual correlation in
mutational effects is strongly positive and coupled to greater
selection in males and/or higher variance in male mating success
(Figs 1 and 2).
The conditions that are predicted to lead to different
evolutionary trajectories of X- and Z-dosage compensation are
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biologically plausible. First, more intense selection in males due to
sexual selection is a standard expectation supported by much
empirical evidence19 and this is also supported by our chicken
transcriptome data. Importantly, the greater intensity of male
selection potentially affects a large number of genes. Thus, genes
under sexual selection need not directly code for male
reproductive traits, such as ornaments or weaponry. More often
than not, male reproductive success depends on general
condition44, which has a much broader genetic basis, including
genes with general effects on viability. In many cases, these genes
are also important for female function and therefore under
selection for similar expression in both sexes. However, sexual
selection tightens the selection pressure for expression in males to
be close to the optimum compared with selection on female
expression. Second, the situation where sexual selection on males
is associated with higher variance in male mating success is
frequent in natural populations18,19. And ﬁnally, it is plausible to
expect a strong positive correlation of mutational effects on gene
expression in males and females. The sexes typically show positive
genetic correlations for the expression of genes (for example, refs
13,14) and new mutations tend to have positively correlated
effects on male and female ﬁtness and phenotypes45,46.
The predictions of our model ﬁnd some support in our analysis
of expression variation on the chicken Z chromosome. Our
analyses show that in the liver, the degree of dosage compensation
of individual genes is more pronounced in genes that are
presumably under strong selection in both sexes, and therefore
show reduced expression variance, and where the intensity of
selection is greater in females than males (Fig. 3, Supplementary
Table 7). Similar relationships were not detected in the other two
tissues analysed. In the gonad, expression evolution is likely to be
strongly inﬂuenced by sex-speciﬁc selection pressures that could
mask the effects we are interested in. However, the difference
between liver and heart is not straightforward to explain. It is
conceivable that the function of the liver is more sensitive to
changes in gene expression. In line with this argument, liver-
expressed genes are on average more dosage compensated than
those expressed in the heart (results not shown). More research is
needed to elucidate the ultimate causes for tissue differences in
regulatory evolution.
Our analysis of gene expression on the chicken Z chromosome
also revealed that the prevalence of dosage compensation is
independent of the age of evolutionary strata in which the genes
reside. This suggests that dosage compensation is saturated within
the time-frame of the youngest stratum of the chicken Z
chromosome (36–68mya) and there does not appear to be
compensation of additional loci beyond this time. One possible
reason for this is that the expression of other Z-linked genes is not
or is no longer sensitive to gene copy number; perhaps because
other unlinked compensatory changes have already taken place.
Alternatively, selection against hypertranscription in the homo-
gametic sex may be sufﬁciently strong to retard further evolution
of compensation in the heterogametic sex. In addition, it is
possible that the low effective population size of the Z
chromosome limits the efﬁcacy of selection for dosage compensa-
tion, and slows its evolution in genes whose expression only
mildly depends on dosage, perhaps again favouring the
evolution of compensatory mechanisms elsewhere in the genome.
However, we note that the youngest stratum in chicken is several
tens of millions of years old, so is not young on an absolute scale.
Further studies are needed in species with younger sex
chromosomes or younger strata to investigate how quickly a
plateau is reached in the rate of dosage compensation evolution of
Z chromosomes.
The model shows that dosage compensation on the X
chromosome evolves via a phase of sexually antagonistic gene
expression due to a positive inter-sexual correlation in mutational
effects and stronger selection on males. Selection on the
heterogametic sex to increase expression towards the optimum
is predicted to result in overshooting of the optimum in the
homogametic sex. There is some evidence for this in the ﬂour
beetle Tribolium castaneum, where the female X chromosome is
thought to be hypertranscribed relative to autosomal expression
levels but the X and autosomes are in dosage parity in males47.
Sexual conﬂict over optimal expression may also be the biological
explanation for compensatory mechanisms that reduce
expression of the X in the homogametic sex. Female-limited
mechanisms that re-establish expression parity between the
female X chromosomes and autosomes are selected once XY
males have approached the optimum expression level (Fig. 1).
Female X inactivation in eutherian mammals48 and the Dpy
complex in C. elegans hermaphrodites49 might be examples of
such mechanisms, as could be the repression of X
hypertranscription during the embryogenesis of female
Drosophila50.
The model also predicts an important role for reproductive
variance and genetic drift in generating differences between species
with XY systems and those with ZW systems. In monogamous
species, the sex-speciﬁc reproductive variance is more often close
to equal between males and females (ZE1), resulting in similar sex
chromosome to autosomal effective population sizes for X and Z
chromosomes (NeX/NeAENeZ/NeAE3/4). Based on our model, we
then expect dosage compensation to evolve at similar rates on the
X and Z. In polygynous species, however, the greater reproductive
skew in males decreases the effective size of the Z much more
than that of the X, as there are two copies of the Z in males
(NeX/NeA43/4, NeZ/NeAo3/4; ref. 51). This asymmetric change
in effective population sizes is expected to result in more rapid
and less stochastic evolution of dosage compensation on the X
compared with the Z (Fig. 2).
Unlike differences in selection that act on individual genes on
the X and Z, differences in the mating system, and hence NeX and
NeZ, affect the evolution of dosage compensation across the whole
X and Z chromosome. They are therefore more apt at explaining
differences in average chromosome-wide dosage compensation
between species. Our preliminary comparison suggests that
dosage compensation is more pronounced in species with XY
systems than those with ZW systems (Table 1). Testing the
contribution of reproductive variance and genetic drift will
require improved comparative analyses, on a larger sample of XY,
as well as ZW species that show lineage-speciﬁc variation in
mating systems. One complication of such analyses will be that
the average difference in selection intensity between the sexes is
expected to covary with the mating system. Polygynous species
are expected to feature increased male reproductive variance, as
well as more intense selection on males. As a consequence,
disentangling the effects of selection and drift may not be
straightforward.
We used a number of assumptions in our modelling to reach
tractable results (considered further in the Supplementary
Discussion). The model’s predictions show a striking similarity
to currently described patterns of dosage compensation, and to
differences in dosage compensation among genes on the chicken
Z. This suggests that the marked difference in dosage compensa-
tion between male and female heterogametic species can be
explained by the combination of genetic correlation for expres-
sion across the sexes, with greater male speciﬁc selection and high
male reproductive variance. Sexual selection on males simulta-
neously increases the strength of selection and reproductive
variance in males, and thus provides a simple and general
explanation for the differences in the evolution of dosage
compensation.
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Methods
Population genetic model of dosage compensation evolution. We model the
co-evolution of male and female gene expression level for X- and Z-linked dose-
sensitive genes. It is assumed that the Y and W copies have undergone degradation
and have no relevant gene expression. In the following, we consider X-linked genes;
the Z-linked case is derived in a similar manner.
Gene expression evolves by the recurrent substitutions of mutations that have
small sex-speciﬁc effects, in a population that in effect remains monomorphic
(for example, see refs 52,53). The population is initially genetically homogeneous,
and expression of the X-linked gene is set at zm in males and zf in females.
A cis-mutation arises and changes male and female expression by dm and df
respectively (Table 2). Mutant effects on expression are additive, in agreement
with data for a large proportion of genes54, and appropriate to model dosage
compensation, which can be generalized as a cis-regulatory additive
mechanism55,56. Mutations are assumed to be sufﬁciently rare for one mutation to
be ﬁxed or lost before another arises52. So we can characterize the expected change
in expression in the population by considering only the probability of ﬁxation of
the mutant, which depends on the life cycle of the population and the ﬁtness effects
of the mutation.
The population is composed of Nmales and N females, and the life cycle follows
a standard Wright–Fisher process57. Generations are non-overlapping. Male and
female adults produce large numbers of gametes that are randomly paired to
produce zygotes. The zygotes are then sampled with replacement and with a
selective bias to form the males and females of the next generation. Since the
population evolves according to a Wright–Fisher process and selection is weak, we
can use Kimura’s equation for sex-linked genes to determine the fate of the
mutants57.
Mutation changes male and female expression level. Whether a mutant is
selectively favoured depends on its effects on male and female ﬁtness. It is assumed
that there is an optimum expression around which ﬁtness declines. The rate at
which ﬁtness decreases from the optimum may differ across the sexes. More
precisely, male and female ﬁtness are given as Gaussian functions of the level z of
expression of the gene, with ﬁtness e Smzm in males and by e Sf zf in females, and
the optimum arbitrarily set at zero (zm¼ 0, zf¼ 0). Greater values for Sm and Sf
reﬂect stronger sex-speciﬁc stabilizing selection. It is possible to have different
optimal levels in males and females; however, this does not change the qualitative
features of our observations.
If the effects of mutations on the level of expression (dm, df) are small and the
population N is large (so that the initial mutation frequency is small), it is
reasonable to linearize Kimura’s equation for the probability that a single copy
X-linked mutant ﬁxes in the population57,
Pr fix j dm; df ; zm; zfð Þ  13N 
2NeX
9N
2Sf zfdf þ Smzmdmð Þ ð5Þ
where NeX is the effective population size of the X chromosome, and captures the
effect of genetic drift, and N is the actual population size, capturing the initial
frequency of a mutant. The ﬁrst term of equation (5) is the probability of ﬁxation of
a neutral X-linked mutant. The terms inside the bracket are the effects of selection
on females and males. Selection increases the probability of ﬁxation if the mutant
pushes the expression rate closer to the optimal level (that is, if zfdfo0 or
zmdmo0). The increase is proportional to the strength of selection in each sex Sf
and Sm, but is twice as strong in females as they have twice as many X
chromosomes compared with males. This lends females a greater importance in the
spread of X mutants.
The probability of ﬁxation determines the expected change in expression over
one particular substitution in each sex. If the mutant is lost, expression does not
change, if the mutant is ﬁxed, male and female expression become zmþ dm and
zfþ 2df, respectively (Table 2). To calculate the expected change in expression, we
consider all possible mutational sizes and their frequencies,
E Dzm j zm; zf½  ¼ 3Nm
Z1
1
Z1
1
dmf dm; dfð ÞPr fix j dm; df ; zm; zfð Þddmddf ð6Þ
E Dzf j zm; zf½  ¼ 3Nm
Z1
1
Z1
1
2df f ðdm; df ÞPr fix j dm; df ; zm; zfð Þddmddf ð7Þ
where 3N is the total number of genes in the population, m is the mutation rate and
f(dm,df) is the probability density function for the effects of mutants on male and
female expression. We assume that f(dm,df) is a bivariate normal distribution with
mean (0, 0) and covariance matrix
s2 rs2
rs2 s2
 
ð8Þ
In this case, equations (6) and (7) read
E Dzm j zm; zf½  ¼  23NeXms
2 Smzm þ 2rSf zfð Þ ð9Þ
E Dzm j zm; zf½  ¼  43NeXms
2 rSmzm þ 2Sf zfð Þ ð10Þ
and the second moments of the change in male and female expressions are approxi-
mately E[(Dzm)2|zm, zf]¼E[(Dzf)2|zm, zf ]¼ s2, and E[(Dzm)(Dzf )|zm, zf ]¼ rs2.
For simplicity, we set s2¼ 0.1. Setting different values for s2 changes the impact
of mutations, but since it does so with the same intensity in males and females,
it does not change our results. However, increasing s2 increases the overall rate of
evolution.
Since selection is weak, the ﬁrst (equations (9) and (10)) and second moments
of the distribution of inﬁnitesimal change in male and female expression are
sufﬁcient to describe the evolution of male and female expression over many
substitutions52,53. In continuous time, and ignoring the time taken for segregation
to occur and the time between mutations, we obtain that the random variables
Zm(t) and Zf(t), which describe male and female expression at time t, satisfy the
stochastic differential equation,
dZm ¼  230NeXm SmZm þ 2rSfZfð Þdtþ
ﬃﬃﬃ
m
p
2
ﬃﬃﬃﬃﬃ
10
p ðb1dWm þ b2dWf Þ ð11Þ
dZf ¼  430NeXm rSmZm þ 2SfZfð Þdtþ
ﬃﬃﬃ
m
p
2
ﬃﬃﬃﬃﬃ
10
p b1dWf þ b2dWmð Þ ð12Þ
where dWm and dWf are standard independent Brownian motions, and b1 and b2
are scaled variance terms given by b1 ¼ ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ1þ rp þ ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ1 rp and
b2 ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1þ rp  ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ1 rp .
Unless selection on male and female expression is very weak (very small NeXSm,
NeXSf), and evolution is dominated by genetic drift, the qualitative features of the
evolution of dosage compensation are captured by the expected trajectory of
equations (11) and (12). Writing the expected male and female expression as zm
and zf, we ﬁnd that their evolution is given by equations (1) and (2), where time is
rescaled according to t¼ 2mt/30. This scaling eases the comparison between X and
Z expression when differences between mutation rates in the two systems are
ignored.
The expected values for male and female expression through time, zm(t) and
zf(t), may be found exactly by solving equations (1) and (2). If we assume that
degradation of the Y-linked gene copy leads to an initial diminution in expression
in males of  z0, and female expression is unperturbed by degradation and remains
at the ancestral optimal level zero, we have
zmðtÞ ¼ z02S Sm  4Sfð Þ e
NeXSt  1  S eNeXSt þ 1  e 12NeX Sm þ 4Sf þ Sð Þt ð13Þ
zf ðtÞ ¼ z0S Smr e
NeXSt  1 e 12NeX Sm þ 4Sf þ Sð Þt ð14Þ
where S ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
Sm  4Sfð Þ2 þ 16SmSfr2
q
. Similar expressions for Z-linked genes can
be found by replacing NeX by NeZ, and m subscripts by f and vice versa. Plots in
Fig. 1 correspond to equations (13) and (14) with respect to t rather than t to
compare more easily the deterministic paths with the stochastic replicates of
equations (11) and (12) that are shown in Fig. 2.
Using standard results of stochastic systems, the properties of equations (11)
and (12) show that after a sufﬁciently long time, male and female expression will
reach an equilibrium distribution that is normally distributed, with mean zero, and
a covariance matrix which can be computed explicitly58. In particular, the variance
in male expression of the X chromosome is given by
1
2NeXSm
1þ 1
1r
 
þ 1
16NeXSm
1
1 r þ
1
1þ r
 
ð15Þ
The variance in female expression of the Z chromosome is found by replacing NeX
by NeZ and by substituting Sf for Sm in equation (15).
Effect of dominant mutations. Our model assumes that the expression of X- and
Z-linked genes evolve by the accumulation of cis-acting mutations, which act locally
on the sex chromosomes and therefore are expected to have additive effects on overall
expression in the homogametic sex (Table 2). Another non-exclusive possibility is that
expression evolves by trans-acting mutations. In contrast to cis mutants, trans
mutants are likely to affect the expression of both gene copies in the homogametic sex,
and therefore correspond to dominant mutants on overall gene expression.
To illustrate the effect of dominant mutations on the evolution of dosage
compensation, we also derive the dynamics of male and female expression when
mutants are completely dominant so that expression in heterozygotes is equal to
expression in mutant homozygotes of the homogametic sex. In that case, the
probability of ﬁxation of a dominant mutant of an X-linked gene is
Pr fix j dm; df ; zm; zfð Þ  13N 
2NeX
9N
8
3
Sf zfdf þ Smzmdm
 
ð16Þ
In contrast to the additive case (equation (5)), equation (16) shows that selection
on the homogametic females is even stronger. For the evolution of dosage
compensation in the presence of correlation in mutational effects across males and
females, this implies that counter-selection in the homogametic sex is inﬂated.
Effect of continuous expression decrease in the heterogametic sex. Our model
investigates the case where the heterogametic sex suffers a decrease in expression
due to the loss of expression of the gene copy on the W or Y. An alternative
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possibility is that once recombination ceases between the sex chromosomes the loss
of expression is a result of gradual gene deterioration. To study the effect of a
continuous decrease in expression on the evolution of dosage compensation, a
time-dependent decline in the expression level of the W- or Y-gene copy is
incorporated.
We consider the case where gene expression in the heterogametic sex is initially
equal on both sex chromosomes. Starting from half the optimal level (z0/2), the
expression of the W- or Y-gene copy then declines over time t according to
z0
2
e at ð17Þ
which models an asymptotic decrease approaching total shut-down as time
progresses. The parameter a40 controls the rate of decrease in expression of the
gene copy. We can then study cis-regulatory evolution of the X- or Z-linked copy in
males and females in the context of the declining Y- or W-linked gene expression.
Fitness in the heterogametic sex then depends on expression from the evolving
expression of the Z- or X-gene copy and time-dependent level of expression from
the W- or Y-gene copy, while ﬁtness in the homogametic sex depends on
expression from both Z- or X-gene copies (Supplementary Table 2).
Expression analysis. All samples were collected with approval by the Zoology
Ethical Review Committee and in accordance with national guidelines. We
obtained fertilized eggs of the White Leghorn chicken breed and kept them under
standard incubator conditions. The left gonad, heart and liver were collected at
embryonic day 19 and stored in RNAlater (Qiagen) until preparation. RNA from
each tissue was prepared with the Animal Tissue RNA Kit (Qiagen). Library and
RNA-sequence samples were prepared by the Wellcome Trust Centre for Human
Genetics Facility at Oxford University using standard methods. Four samples
per sex were prepared for each of the four tissues, and each individual was
barcoded so that individual variation in coding sequence and expression level could
be tracked. Samples were sequenced using Illumina HiSeq as paired-end 100-bp
reads, resulting in 16 million paired-end mappable reads per sample, on average.
To minimize technical sources of variance, the same HiSeq machine was used for
all samples.
Resulting RNA-Seq data were assessed for quality using FastQC v0.10.1 (ref. 59)
and ﬁltered using Trimmomatic v0.22 (ref. 60). Filtered reads were mapped to the
chicken reference genome (ENSEMBL version 68 WASHUC2) using TopHat v2.05
(refs 61,62) and Bowtie2 v2.0.0-beta7 (ref. 63), allowing up to two mismatches per
alignment. For each tissue separately, aligned reads were sorted and indexed using
Samtools v0.1.18 (ref. 64) and raw read counts extracted using Htseq-count
v0.5.4p3 (ref. 59). After removing genes for which no read was detected in any
sample, raw read counts were normalized across libraries. We used the weighted
trimmed mean of M-values method in EdgeR v3.2.4 (ref. 65). To limit the impact
of incomplete dosage compensation on this step, normalization factors were
estimated based on autosomal genes only. Relative transcript abundances were then
estimated for all expressed genes as reads per kilobase of exon per million mapped
reads (RPKM).
Statistical analysis of expression data. To ﬁlter out noisy gene expression for
each tissue, genes were excluded if they were not expressed in all individuals of at
least one sex (log2(RPKM)o1 for any sample)32. For all genes retained, we
determined the male-to-female expression ratio as log2(average male RPKM/
average female RPKM)¼ log2(average male RPKM) log2(average female RPKM).
We further estimated the variability of gene expression as an inverse measure of
stabilizing selection on expression levels. To quantify expression variability, we
used log2 of the BCV as estimated by EdgeR. The package implements Bayesian
procedures that—based on a negative binomial model—decompose the across-
sample variance in read counts for a gene into a part of technical, Poisson-
distributed variance and a part of biological variation that stems from true
expression differences between samples. The BCV is the square-root of the estimate
biological variation divided by the mean expression level of a gene. We estimated
BCVs separately for each tissue and sex. The value of the prior, which governs the
relative importance of expression variance across all genes and gene-speciﬁc
expression variance in the estimation of BCVs, was set to 10. Based on preliminary
analysis, this value achieved a good balance between capturing gene-speciﬁc effects,
while minimizing the number of genes with zero estimates of BCV. Using different
priors produced qualitatively equivalent results.
Validation of BCV as a measure for selection strength. We ﬁrst performed
analyses to validate our estimates of BCVs and their interpretation as meaningful
measures of selection on expression levels. First, we veriﬁed that the estimation of
expression variance had successfully removed Poisson-distributed error in read
counts by correlating sex- and tissue-speciﬁc estimates of BCV with average
expression levels across autosomal and Z-linked genes. Next, we veriﬁed the
relationship between BCV and selective constraint on protein coding sequences,
measured as the rate of non-synonymous to synonymous substitutions (dN/dS).
Gallus gallus, Meleagris gallopavo, Taeniopygia guttata and Anolis carolinensis
complementary DNA sequences were obtained from Ensembl, and orthologues
were established using reciprocal blastn66. Orthologous sequences were aligned
using PRANK67 and only included in subsequent analyses if the length of the
alignment without gaps was433 amino acids. dN/dS for each gene for the terminal
G. gallus branch was estimated using the branch model in the CODEML package in
PAML68. Orthologues were excluded if dS42 as double hits and mutational
saturation can lead to inaccurate divergence estimates69. To avoid noise due to
genes with poor rate estimates, orthologues were also only included in subsequent
analyses if there was at least one non-synonymous or one synonymous
substitution, and the total number of substitutions was greater than three on the
terminal G. gallus branch.
Because estimates of BCV were negatively correlated with expression levels, and
high expression levels have been shown to be associated with selective constraint
on coding sequence42, we performed multiple regression analysis of rates of protein
evolution (dN/dS) as a function of average expression level (average RPKM across
samples) and BCV (all variables log2 transformed). The two predictor variables
were entered in this speciﬁc order to estimate the association between BCV and
rates of protein evolution over and above the effect of average expression levels.
Analyses were performed separately for each sex with expression levels and BCV
averaged across males and females, as well as separately for each tissue and sex.
Dosage compensation across Z-chromosomal strata. To analyse variation in
dosage compensation across the Z chromosome, we ﬁltered genes based on their
male-to-female expression ratio. To avoid biasing our analyses by the confounding
effects of sex-biased or sex-limited expression, we removed all genes that had
strongly sex-biased expression. Speciﬁcally, we removed genes with expression
ratios 4log2 (1.25/0.5) and olog2 (1/1.25). This ﬁltering removed a limited
number of genes from the somatic tissues (422 of 433 genes retained for the heart
and 364 of 381 retained for the liver), but more from the gonads (427/534
retained). For all genes passing this ﬁlter, we projected male and female expression
variability (log2 BCV) onto two perpendicular axes, one describing the intensity of
sexually concordant selection strength (with values increasing as selection becomes
stronger in males and female) and one describing the male bias in selection
intensity (values increasing as selection becomes stronger in males and/or weaker
in females). The coordinates of the genes on the two axes were then used to
determine the effects of selection on male-to-female expression ratios. Trans-
forming selection intensities in this way eliminates problems in subsequent ana-
lyses that arise from the correlation between male and female selection and
facilitates the interpretation of results.
We analysed variation in dosage compensation across all Z-linked genes and
tissues using linear models of male-to-female expression ratio (dependent variable,
as log2(male RPKM/female RPKM)) as a function of concordant selection intensity,
male bias in selection intensity, tissue and their interactions. In line with previous
analyses of dosage compensation, our approach assumes statistical independence
between genes expressed in the same tissue. We also assume independence between
expression measures from the same genes measured in different tissues. However,
this assumption does not affect our conclusions; all reported tissue-speciﬁc effects
of the selection measures are also detected when performing analyses separately on
each tissue-speciﬁc data set.
We tested whether the age of chromosomal strata had an effect on the level of
dosage compensation, over and above that of the two measures of selection strength.
We ran an analysis modelling log2 male-to-female expression ratio as a function of
the two measures of selection strength, tissue, the age of each gene’s chromosomal
stratum, as well as all the interactions between these terms. Genes that could not be
unambiguously assigned to the three major strata were excluded from this analysis.
In addition to assessing dosage compensation using the Z-linked log2 male-to-female
expression ratio, we also calculated the expression ratio of the single Z chromosome
and autosomes in females (Z:AA) and males (ZZ:AA) across each stratum.
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